Download Unicorn Signals App

Powered By EquityPandit
 Signals, Powered By  EquityPandit
Latest News

Strides Shasun gets USFDA nod for antihistamine drug

Strides Shasun’s wholly owned subsidiary Strdies Pharma Global Pte Ltd, has received approval for antihistamine drug, from the US health regulator.

Cyproheptadine is an antihistamine used to relieve allergy symptoms like watery eyes, runny nose, itching eyes/nose, sneezing, hives, and itching. It works by blocking a certain natural substance (histamine) that your body makes during an allergic reaction. Cyproheptadine hydrochloride tablets is a generic version of Periactin tablets of Merck & Co Inc.

Further the company stated, “The product will be manufactured at oral dosage facility at Bangalore and will be marketed by Strides Pharma Inc in the US market.”

Read EquityPandit’s Technical Analysis of Nifty Pharma

Get Daily Prediction & Stocks Tips On Your Mobile